Alan Meds Keeps Tirzepatide Pricing Undisclosed, Review Finds
Consumer report says the telehealth provider does not publish tirzepatide costs, limiting patient price comparison.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 14 23:52 ETSource: PlexusDx
The wire
- 01Review reports Alan Meds has not made tirzepatide pricing public.
- 02Opaque pricing complicates cost comparison for GLP-1 patients.
- 03Actual costs remain unknown pending company disclosure.
From the source
Read at news.google.comAlan Meds Tirzepatide Cost: Pricing Not Public, What We Know in 2026